RSS
Preterax(R) Prevents and Reverses Renal Disease in Type 2 Diabetics
Berlin (ots/PRNewswire) - New results of the ADVANCE (Action in Diabetes and Vascular disease: PreterAx and DiamicroN-MR Controlled Evaluation) trial have been presented today at the European Society of Hypertension (ESH) and show that the antihypertensive Preterax - a fixed combination of the ACE-inhibitor perindopril and the diuretic indapamide - reduces the likelihood of new or worsening nephropathy (kidney damage) in patients with type ... weiter zur Meldung von Servier Laboratories
Major International Diabetes Study Does not Confirm Increased Risk of Death Reported by US Trial
Paris (ots/PRNewswire) - - Preliminary Findings from the Largest-Ever Study of Treatments for Diabetes Provide no Evidence That Intensive Treatment to Lower Blood Glucose (Sugar) Increases Risk of Death Interim results from the ADVANCE ... weiter zur Meldung von Servier Laboratories
